Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

Exclusion Criteria

• •Previous surgical or catheter ablation for AF
• •Documented LA thrombus by imaging within 48 hours before procedure (CT, TEE, or intracardiac echocardiogram at the beginning of the procedure).
• •Uncontrolled heart failure or New York Heart Association (NYHA) Class IV
• •History of blood clotting, bleeding abnormalities or contraindication to anticoagulation (heparin, warfarin, or dabigatran)
• •Significant congenital anomaly or medical problem that in the opinion of the investigator would preclude enrollment in this study
• •Presence of implanted pacemaker or Implantable Cardioverter-Defibrillator (ICD) or other implanted metal cardiac device that may interfere with the PFA energy field
• •Women who are pregnant (as evidenced by pregnancy test if pre- menopausal), lactating, or who are of child-bearing age and plan on becoming pregnant during the course of the clinical investigation
• •Life expectancy less than 12 months
• •Currently enrolled in an investigational study evaluating another device, biologic, or drug that would interfere with this trial